Evidence map›Paper›PMID 38199780›Full record

ArticleCold Spring Harbor molecular case studies2023

PD-L1

Andrew W Allbee, James Gerson, Guang Yang, Adam Bagg

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Cold Spring Harbor molecular case studies, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Andrew W AllbeeDivision of Hematopathology, Department of Pathology and Laboratory Medicine, Perelman School of Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.ORCID 0009-0006-7765-0038
James GersonDepartment of Hematology and Medical Oncology, Larner College of Medicine, University of Vermont Medical Center, Burlington, Vermont 05405, USA.ORCID 0000-0002-4736-187X
Guang YangDivision of Hematopathology, Department of Pathology and Laboratory Medicine, Perelman School of Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
Adam BaggDivision of Hematopathology, Department of Pathology and Laboratory Medicine, Perelman School of Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA; adambagg@pennmedicine.upenn.edu.ORCID 0000-0002-1669-468X
Hospital of the University of Pennsylvania · USUniversity of Vermont Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We present a unique case of a single patient presenting with two mutationally distinct, PD-L1

Indexed as

B7-H1 AntigenLymphoma, Large B-Cell, DiffuseHumansMicrosatellite InstabilityMismatch Repair Endonuclease PMS2MutationB7-H1 AntigenMismatch Repair Endonuclease PMS2PMS2 protein, humanB-cell lymphoma

Identifiers

PMID38199780
PMCPMC10815288
OpenAlexW4390711115

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.